NEU 1.23% $19.26 neuren pharmaceuticals limited

Reformulation likely lead to parents retrying with hopefully...

  1. 2,357 Posts.
    lightbulb Created with Sketch. 736
    Reformulation likely lead to parents retrying with hopefully less side effects as well
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.